NVAX Novavax, Inc. Stock Quote

NVAX [NASD]

Index	-	P/E	-	EPS (ttm)	-13.71	Insider Own	0.20%	Shs Outstand	74.12M	Perf Week	-1.71%
Market Cap	17.13B	Forward P/E	7.13	EPS next Y	32.30	Insider Trans	-56.72%	Shs Float	73.93M	Perf Month	-0.26%
Income	-949.90M	PEG	-	EPS next Q	-3.91	Inst Own	55.20%	Short Float	8.22%	Perf Quarter	18.48%
Sales	1.18B	P/S	14.50	EPS this Y	-32.00%	Inst Trans	-4.67%	Short Ratio	1.24	Perf Half Y	4.75%
Book/sh	10.06	P/B	22.89	EPS next Y	416.40%	ROA	-48.20%	Target Price	264.20	Perf Year	109.07%
Cash/sh	27.89	P/C	8.26	EPS next 5Y	0.00%	ROE	-150.90%	52W Range	76.59 - 331.68	Perf YTD	106.52%
Dividend	-	P/FCF	28.91	EPS past 5Y	9.50%	ROI	-38.00%	52W High	-30.57%	Beta	1.53
Dividend %	-	Quick Ratio	1.40	Sales past 5Y	67.30%	Gross Margin	-	52W Low	200.67%	ATR	15.85
Employees	791	Current Ratio	1.40	Sales Q/Q	739.40%	Oper. Margin	-78.80%	RSI (14)	47.67	Volatility	4.85% 6.18%
Optionable	Yes	Debt/Eq	0.58	EPS Q/Q	-	Profit Margin	-80.40%	Rel Volume	0.58	Prev Close	226.92
Shortable	Yes	LT Debt/Eq	0.45	Earnings	Aug 05 AMC	Payout	-	Avg Volume	4.90M	Price	230.29
Recom	2.20	SMA20	-5.11%	SMA50	3.94%	SMA200	19.82%	Volume	2,841,163	Change	1.49%

May-12-21

Downgrade

JP Morgan

Overweight → Neutral

$285 → $161

Dec-14-20

Initiated

Jefferies

Buy

$200

Aug-06-20

Reiterated

H.C. Wainwright

Buy

$132 → $290

Aug-05-20

Upgrade

JP Morgan

Neutral → Overweight

$275

Aug-05-20

Downgrade

Ladenburg Thalmann

Neutral → Sell

$105

Jul-16-20

Reiterated

H.C. Wainwright

Buy

$101 → $132

Jul-08-20

Downgrade

Ladenburg Thalmann

Buy → Neutral

$50 → $105

Jun-29-20

Reiterated

H.C. Wainwright

Buy

$50 → $101

Jun-29-20

Reiterated

B. Riley FBR

Buy

$74 → $106

Jun-05-20

Upgrade

JP Morgan

Underweight → Neutral

$46

May-28-20

Reiterated

B. Riley FBR

Buy

$53 → $61

May-12-20

Reiterated

H.C. Wainwright

Buy

$33 → $50

Apr-30-20

Reiterated

H.C. Wainwright

Buy

$24 → $33

Nov-27-19

Resumed

B. Riley FBR

Buy

$12

Aug-14-19

Reiterated

H.C. Wainwright

Buy

$10 → $17

Feb-28-19

Downgrade

Piper Jaffray

Overweight → Underweight

$4.50 → $0.25

Dec-18-18

Initiated

Ladenburg Thalmann

Buy

Dec-11-18

Initiated

Oppenheimer

Outperform

Nov-26-18

Upgrade

Piper Jaffray

Neutral → Overweight

Sep-21-18

Upgrade

JP Morgan

Underweight → Overweight

Sep-21-21 05:50PM	Novavax (NVAX) Gains As Market Dips: What You Should Know Zacks
05:31PM	Could natural COVID-19 immunity trump vaccine mandates? Yahoo Finance Video
03:25PM	Is Novavax Stock A Buy After Planning To Combine Its Covid, Flu Shots? Investor's Business Daily
11:21AM	Analyst Sees Novavax Covid Vaccine as Potentially Useful to Boost Other Vaccines TipRanks
05:51AM	I'm Sitting On a Record Amount of Cash: Here Are 5 Stocks I'm Looking to Buy Motley Fool
Sep-20-21 04:50PM	Doctor reacts to U.S. travel ban changes Yahoo Finance Video
04:46PM	Novavax to Participate in Fireside Chat at Devex @ UNGA 76 PR Newswire
04:05PM	Novavax to Participate in Fireside Chat at Devex @ UNGA 76 PR Newswire
02:23PM	LAPD, LAFD members sue over Los Angeles vaccine mandate Yahoo Finance Video
01:42PM	Early tests show Pfizers Covid-19 vaccine for kids ages 5 to 11 is very safe: Epidemiologist Yahoo Finance Video
Sep-17-21 04:41PM	FDA advisory panel authorizes booster dose for those 65 & older Yahoo Finance Video
03:59PM	FDA advisory panel votes against approving COVID-19 booster Yahoo Finance Video
03:56PM	Wearing masks is something we should consider possibly in every flu, winter season: Doctor Yahoo Finance Video
02:56PM	7 Top Robinhood Stocks to Buy Heading Into Q4 InvestorPlace
02:29PM	Impact of NYCs Covid-19 vaccination proof mandate for restaurants Yahoo Finance Video
02:09PM	Doctor: This conversation about boosters doesnt take place just in the U.S. Yahoo Finance Video
01:42PM	British Study To Test Mixed COVID-19 Vaccine Regime In Kids: Reuters Benzinga
11:17AM	Why COVID Vaccine Stocks BioNTech, Moderna, and Novavax Are Sliding While Ocugen Is Rising Motley Fool
05:51AM	The Smartest Stocks to Buy With $500 Right Now Motley Fool
Sep-16-21 07:02PM	Novavax to Participate in University of Oxford Com-COV3 Study Comparing Mixed COVID-19 Vaccine Schedule in Adolescents PR Newswire
10:40AM	Is Novavax (NASDAQ:NVAX) Using Debt In A Risky Way? Simply Wall St.
Sep-15-21 05:00PM	Moderna President details new clinical data on COVID-19 vaccine Yahoo Finance Video
02:40PM	Biden meets with CEOs, business leaders on vaccine mandates Yahoo Finance Video
01:51PM	Doctor on Bidens vaccine mandate: Extraordinary times call for extraordinary measures Yahoo Finance Video
01:00PM	3 COVID Stocks That Might Double Soon Motley Fool
10:25AM	Is Novavax Stock A Buy After Planning To Combine Its Covid, Flu Shots? Investor's Business Daily
06:00AM	Is Novavax a Buy? Motley Fool
Sep-14-21 05:45PM	Novavax (NVAX) Gains As Market Dips: What You Should Know Zacks
06:20AM	Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now? Zacks
Sep-13-21 03:33PM	Moderna Stock Is Tanking After a Review Arguing That Covid Vaccine Boosters Arent Needed Barrons.com
02:14PM	Florida turns to Covid-detecting dogs amid surging cases Yahoo Finance Video
01:40PM	NYC has a good plan so far for keeping kids safe as they return to the classroom: Doctor Yahoo Finance Video
01:16PM	Novavax (NVAX) Stock Surges YTD as COVID Vaccine Advances Well Zacks
Sep-11-21 06:00AM	Here's Where Novavax May Beat Moderna and Pfizer Motley Fool
05:55AM	2 Biotech Stocks That Are Better Buys Than Moderna Motley Fool
Sep-10-21 04:42PM	4 Top Stock Trades for Monday: NVAX, FCEL, KR, PLAY InvestorPlace -6.41%
04:31PM	Novavax expects to make available at least 2 bln COVID-19 vaccine doses in 2022 Reuters
01:46PM	Novavax Could Rise 56% Once Its Covid-19 Vaccine Is Approved InvestorPlace
12:26PM	Why Novavax Stock Is Slipping Again Today Motley Fool
11:21AM	How Novavax Stock Can Rally 30% to New Highs InvestorPlace
06:52AM	What Should Novavax Investors Make of the CDC's Latest Guidance? Motley Fool
Sep-09-21 03:52PM	Why Novavax Stock Slipped Today Motley Fool
03:28PM	Norfolk State University President on its vaccine incentive program Yahoo Finance Video
02:24PM	Covid vaccine potentially causing infertility is a complete myth at this point: Doctor Yahoo Finance Video
10:33AM	The economy is in a good spot in terms of corporate profitability and outlook: strategist Yahoo Finance Video
10:32AM	Novavax (NVAX) Begins Clinical Study on COVID/Flu Combo Jab Zacks
09:25AM	Novavax to Participate in Upcoming September Conferences PR Newswire
07:38AM	Novavax Slips on Report India Launch May Take More Time Investing.com
Sep-08-21 01:37PM	If you dont get vaccinated, you will get Covid at this point: Doctor Yahoo Finance Video
11:47AM	Novavax Starts COVID-19, Flu Combination Vaccine Trial Benzinga
08:48AM	UPDATE 1-Novavax begins early-stage trial for combined influenza/COVID-19 vaccine Reuters
08:30AM	Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza PR Newswire
08:16AM	Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza PR Newswire
Sep-07-21 05:39PM	Why Novavax Stock Surged Today Motley Fool +7.59%
02:12PM	Vaccination is still working incredibly well as bolstering our immune response to Covid: Doctor Yahoo Finance Video
11:32AM	Why Novavax Stock Is Up By 7% Today FX Empire
09:05AM	Novavax to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021 PR Newswire
07:51AM	Novavax Jumps as Japan to Buy 150 million Doses of Covid Vaccine Investing.com
Sep-06-21 10:53PM	Japan to purchase 150 mln doses of Takeda-produced Novavax vaccines - drugmaker Reuters
05:52AM	This Could Be Novavax's Ace in the Hole Motley Fool
Sep-05-21 05:51AM	5 Game-Changing Stocks That Can Turn $5,000 Into $50,000 (or More) by 2035 Motley Fool
Sep-03-21 01:58PM	A large prevalence rate of the virus is going to affect everyone: Doctor Yahoo Finance Video
06:00AM	Novavax Stock Is a Steal Here If You Believe It Will Come Through InvestorPlace
Sep-02-21 04:48PM	Former Biden COVID-19 adviser calls for vaccine mandate for teens Yahoo Finance Video
03:23PM	Todos Medical launches test that measures COVID-19 antibody levels Yahoo Finance Video
02:18PM	Data is starting to support the need & timeline for a Covid-19 booster vaccine: Virologist Yahoo Finance Video
Sep-01-21 06:01PM	Novavax Covid-19 Vaccine Could Be the Solution to Emerging Variants TipRanks +5.67%
02:14PM	All the teachers should be mandated now to get the vaccine: Doctor Yahoo Finance Video
12:10PM	Why Novavax Stock Is Jumping Again Today Motley Fool
05:51AM	3 Top Stocks That'll Make You Richer in September (and Beyond) Motley Fool
Aug-31-21 04:37PM	COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments? Motley Fool
04:04PM	Doctor: Pediatric hospital units are 'getting stretched' due to Delta variant Yahoo Finance Video
03:36PM	Why Novavax Stock Is Trading Higher Today Benzinga
11:46AM	Why Novavax Stock Is Rising Today Motley Fool
08:18AM	Novavax Up as Covid Shot Trial Volunteers Count as Fully Vaccinated Investing.com
Aug-30-21 05:18PM	Doctor on booster shots: 'What we may be talking about is a vaccine that requires 3 shots' Yahoo Finance Video
04:37PM	Novavax COVID-19 vaccine U.S. trial participants count as fully vaccinated two weeks after dosing -CDC Reuters
04:07PM	Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants PR Newswire
02:06PM	Early polls & surveys show theres about a 25% likelihood that parents are going to vaccinate their kids: Doctor Yahoo Finance Video
05:51AM	5 No-Brainer Stocks to Invest $400 in Right Now Motley Fool
Aug-29-21 11:45PM	It Was a Big Week for Covid Vaccine News. What Stocks Came Out on Top. Barrons.com
05:52AM	3 Reasons Why Novavax Stock Will Likely Beat Moderna Over the Next Year Motley Fool
Aug-27-21 02:07PM	SCAN Health Plan CEO on reducing Covid-19 vaccine disparities among minorities Yahoo Finance Video
10:40AM	Which Biotech Stock Will Shock the Market in 2022? Motley Fool
06:06AM	4 Large-Cap Stocks Expected to Increase Sales 508% to 1,118% by 2024 Motley Fool
Aug-26-21 05:22PM	Emergency medicine physician: Delta has 'changed the game' for COVID-19 Yahoo Finance Video
03:02PM	Best practices on how to prove your Covid-19 vaccination status Yahoo Finance Video
02:37PM	The cost of being unvaccinated in the U.S. Yahoo Finance Video
Aug-25-21 06:06PM	Alabama doctor explains COVID-19 situation in the South Yahoo Finance Video
01:38PM	I am in favor of companies adopting these strong policies about covid vaccination & mandating it: Doctor Yahoo Finance Video
12:03PM	Why Shares of Moderna and Novavax Are Higher This Morning Motley Fool
09:27AM	Novavax to Participate in OCTAVE-DUO Study to Evaluate Third Dose of Vaccine in Participants with Impaired Immune Systems PR Newswire
Aug-24-21 05:29PM	Doctor: 'If you want to question [the efficacy of vaccines], youre betting against the house' Yahoo Finance Video -7.17%
02:16PM	The covid booster question is one of privilege and we must be very thoughtful about: Doctor Yahoo Finance Video
11:45AM	Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Sinking Today Motley Fool
09:57AM	Hopes of Moderna (MRNA) Vaccine Approval Boost Biotech Investopedia
09:40AM	3 COVID Vaccine Makers to Watch on Pfizer Jab Full FDA Approval Zacks
Aug-23-21 01:57PM	The FDA approval of Pfizers COVID-19 vaccine is a critical step forward in vaccine confidence: Doctor Yahoo Finance Video +8.71%
05:50AM	5 No-Brainer Stocks to Invest $1,000 in Right Now Motley Fool
Aug-22-21 09:01AM	3 Top COVID Vaccine Stocks That Wall Street Is Bullish About Motley Fool

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Glenn Gregory M	President, R&D	Sep 15	Option Exercise	37.90	1,183	44,832	5,244	Sep 17 05:08 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 15	Option Exercise	19.08	5,000	95,400	5,706	Sep 17 05:11 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 15	Sale	229.44	5,000	1,147,193	706	Sep 17 05:11 PM
Glenn Gregory M	President, R&D	Sep 15	Sale	229.34	1,183	271,304	4,061	Sep 17 05:08 PM
Trizzino John	EVP, CCO and CBO	Sep 14	Option Exercise	19.08	7,499	143,081	8,217	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 14	Sale	236.61	7,499	1,774,360	718	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 13	Option Exercise	19.08	7,499	143,081	8,217	Sep 15 05:03 PM
Trizzino John	EVP, CCO and CBO	Sep 13	Sale	235.29	7,499	1,764,433	718	Sep 15 05:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 01	Option Exercise	19.08	5,000	95,400	5,706	Sep 03 05:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 01	Sale	247.97	5,000	1,239,867	706	Sep 03 05:10 PM
Glenn Gregory M	President, R&D	Aug 31	Sale	239.87	1,386	332,463	4,061	Sep 01 05:23 PM
Glenn Gregory M	President, R&D	Aug 26	Option Exercise	5.95	6,921	41,180	8,228	Aug 30 06:16 PM
Glenn Gregory M	President, R&D	Aug 26	Sale	233.92	4,167	974,740	4,061	Aug 30 06:16 PM
Glenn Gregory M	President, R&D	Aug 16	Option Exercise	40.64	1,866	75,826	5,927	Aug 18 05:26 PM
Glenn Gregory M	President, R&D	Aug 16	Sale	233.52	1,866	435,750	4,061	Aug 18 05:26 PM
Herrmann John A III	EVP, Chief Legal Officer	Jul 26	Option Exercise	14.83	2,896	42,960	3,602	Jul 28 05:00 PM
Herrmann John A III	EVP, Chief Legal Officer	Jul 26	Sale	197.74	2,896	572,648	706	Jul 28 05:00 PM
Glenn Gregory M	President, R&D	Jul 20	Sale	215.43	2,409	518,982	2,811	Jul 22 05:20 PM
Glenn Gregory M	President, R&D	Jul 15	Option Exercise	13.08	10,477	137,006	8,465	Jul 19 07:52 PM
Glenn Gregory M	President, R&D	Jul 15	Sale	179.45	5,654	1,014,597	2,811	Jul 19 07:52 PM
Erck Stanley C	President and CEO	Jul 02	Option Exercise	80.66	52,559	4,239,511	73,054	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 02	Sale	215.89	52,559	11,347,066	20,495	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 01	Option Exercise	61.59	52,620	3,240,965	73,115	Jul 06 05:03 PM
Erck Stanley C	President and CEO	Jul 01	Sale	212.88	52,620	11,201,513	20,495	Jul 06 05:03 PM
Glenn Gregory M	President, R&D	Jun 17	Sale	183.28	2,411	441,887	2,811	Jun 17 06:17 PM
Glenn Gregory M	President, R&D	Jun 15	Option Exercise	13.16	10,535	138,685	8,527	Jun 17 06:17 PM
Glenn Gregory M	President, R&D	Jun 15	Sale	191.42	5,716	1,094,130	2,811	Jun 17 06:17 PM
EVANS GARY C	Director	Jun 01	Sale	146.50	625	91,562	0	Jun 03 05:34 PM
Herrmann John A III	EVP, Chief Legal Officer	May 28	Option Exercise	14.83	2,895	42,932	3,170	Jun 02 04:59 PM
Herrmann John A III	EVP, Chief Legal Officer	May 28	Sale	149.14	2,895	431,748	275	Jun 02 04:59 PM
King Rachel K.	Director	May 19	Buy	139.64	700	97,748	2,800	May 21 05:06 PM
Glenn Gregory M	President, R&D	May 19	Sale	142.17	2,385	339,066	2,811	May 19 05:26 PM
Glenn Gregory M	President, R&D	May 17	Option Exercise	13.16	10,531	138,577	8,523	May 19 05:26 PM
Glenn Gregory M	President, R&D	May 17	Sale	133.98	5,712	765,267	2,811	May 19 05:26 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 07	Sale	176.63	190	33,559	287	May 07 05:10 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 05	Option Exercise	14.73	3,406	50,160	3,309	May 07 05:10 PM
Trizzino John	EVP, CCO, CBO & Interim CFO	May 05	Sale	185.46	3,022	560,471	287	May 07 05:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Apr 30	Option Exercise	14.82	2,895	42,892	3,170	May 04 06:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Apr 30	Sale	239.83	2,895	694,317	275	May 04 06:03 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 07	Sale	178.03	191	34,004	287	Apr 07 05:09 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 05	Option Exercise	34.01	3,404	115,771	3,308	Apr 07 05:09 PM
Trizzino John	EVP, Chief Commercial Officer	Apr 05	Sale	190.10	3,021	574,292	287	Apr 07 05:09 PM
Herrmann John A III	EVP, Chief Legal Officer	Mar 26	Option Exercise	14.82	2,894	42,886	3,169	Mar 30 06:10 PM
Herrmann John A III	EVP, Chief Legal Officer	Mar 26	Sale	186.80	2,894	540,609	275	Mar 30 06:10 PM
YOUNG JAMES F	Director	Mar 25	Option Exercise	8.96	47,500	425,438	57,500	Mar 25 06:41 PM
YOUNG JAMES F	Director	Mar 23	Option Exercise	46.00	10,000	460,000	20,000	Mar 25 06:41 PM
YOUNG JAMES F	Director	Mar 23	Sale	228.22	10,000	2,282,231	10,000	Mar 25 06:41 PM
MCMANUS MICHAEL A JR	Director	Mar 19	Sale	220.78	4,000	883,110	5,951	Mar 23 05:33 PM
Glenn Gregory M	President, R&D	Mar 17	Sale	218.86	2,423	530,304	2,811	Mar 17 06:35 PM
Glenn Gregory M	President, R&D	Mar 15	Option Exercise	109.95	10,531	1,157,843	8,523	Mar 17 06:35 PM
EVANS GARY C	Director	Mar 15	Option Exercise	19.52	24,500	478,330	40,599	Mar 17 06:36 PM
EVANS GARY C	Director	Mar 15	Sale	211.21	24,500	5,174,536	16,099	Mar 17 06:36 PM
Glenn Gregory M	President, R&D	Mar 15	Sale	198.60	5,712	1,134,400	2,811	Mar 17 06:35 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 09	Sale	168.09	190	31,937	287	Mar 09 07:38 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 05	Option Exercise	14.73	3,404	50,148	3,308	Mar 09 07:38 PM
Trizzino John	EVP, Chief Commercial Officer	Mar 05	Sale	163.46	3,021	493,824	287	Mar 09 07:38 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Option Exercise	14.82	2,895	42,892	3,170	Mar 02 05:37 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 26	Sale	225.48	2,895	652,759	275	Mar 02 05:37 PM
Glenn Gregory M	President, R&D	Feb 18	Sale	269.57	2,434	656,134	2,811	Feb 18 06:59 PM
Glenn Gregory M	President, R&D	Feb 16	Option Exercise	13.16	10,531	138,577	8,523	Feb 18 06:55 PM
Glenn Gregory M	President, R&D	Feb 16	Sale	282.71	5,712	1,614,812	2,811	Feb 18 06:55 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 09	Sale	324.50	194	62,953	287	Feb 09 07:40 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 05	Option Exercise	14.73	3,406	50,160	3,309	Feb 09 07:40 PM
Trizzino John	EVP, Chief Commercial Officer	Feb 05	Sale	290.46	3,022	877,766	287	Feb 09 07:40 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 01	Option Exercise	18.15	15,022	272,724	15,297	Feb 03 05:37 PM
Herrmann John A III	EVP, Chief Legal Officer	Feb 01	Sale	241.50	15,022	3,627,789	275	Feb 03 05:37 PM
Trizzino John	EVP, CMO and CBO	Jan 07	Sale	124.17	506	62,830	287	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Option Exercise	18.63	13,756	256,243	17,694	Jan 07 07:08 PM
Trizzino John	EVP, CMO and CBO	Jan 05	Sale	112.00	17,407	1,949,522	287	Jan 07 07:08 PM
YOUNG JAMES F	Director	Dec 31	Option Exercise	51.27	11,000	564,000	11,000	Jan 05 05:38 PM
DOUGLAS RICHARD	Director	Dec 31	Option Exercise	50.00	1,000	50,000	28,500	Jan 05 05:42 PM
YOUNG JAMES F	Director	Dec 31	Sale	113.09	11,000	1,244,014	0	Jan 05 05:38 PM
Erck Stanley C	President and CEO	Nov 16	Option Exercise	37.14	52,317	1,942,801	72,811	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Nov 16	Sale	90.65	52,316	4,742,667	20,495	Nov 18 06:09 PM
Erck Stanley C	President and CEO	Oct 01	Sale	108.56	2	217	20,494	Oct 01 05:39 PM
Trizzino John	EVP, CBO and CFO	Sep 30	Sale	110.22	2,250	248,002	5,087	Oct 01 05:40 PM
Erck Stanley C	President and CEO	Sep 30	Sale	110.23	12,231	1,348,200	20,496	Oct 01 05:39 PM
Glenn Gregory M	President, R&D	Sep 29	Sale	107.02	19,949	2,134,844	1,561	Sep 30 09:29 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 29	Sale	107.31	18,029	1,934,667	275	Sep 30 09:30 PM
Trizzino John	EVP, CBO and CFO	Sep 29	Sale	107.29	18,321	1,965,630	7,337	Sep 30 09:28 PM
Erck Stanley C	President and CEO	Sep 29	Sale	107.80	4,112	443,267	32,727	Sep 30 09:27 PM
Erck Stanley C	President and CEO	Sep 28	Option Exercise	5.95	50,000	297,500	74,606	Sep 30 09:27 PM
Glenn Gregory M	President, R&D	Sep 28	Option Exercise	5.95	25,000	148,750	46,510	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Option Exercise	5.95	29,600	176,120	53,008	Sep 30 09:28 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Option Exercise	5.95	24,750	147,262	43,054	Sep 30 09:30 PM
Herrmann John A III	EVP, Chief Legal Officer	Sep 28	Sale	110.30	24,750	2,729,879	18,304	Sep 30 09:30 PM
Glenn Gregory M	President, R&D	Sep 28	Sale	110.30	25,000	2,757,456	21,510	Sep 30 09:29 PM
Trizzino John	EVP, CBO and CFO	Sep 28	Sale	110.30	25,000	2,757,456	25,658	Sep 30 09:28 PM
Erck Stanley C	President and CEO	Sep 28	Sale	110.30	25,000	2,757,456	36,839	Sep 30 09:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience